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Background
Cyclophilins are distributed widely among different
organisms and are proposed drug targets for a number
of diseases including HIV and hepatitis C infection and
ischemia. Cyclophilins play roles in folding and chaper-
oning of cellular proteins and are the major receptors
for the immunosuppressive drug cyclosporin A (CsA).
CsA and certain non-immunosuppressive derivatives
(e.g., valspodar) possess potent antimalarial activity. We
are interested in the role (if any) played by cyclophilins
in parasite killing by cyclosporins. We, and others, have
previously characterized two CsA-binding cyclophilins
(PfCYP19A and PfCYP19B) but a family of genes encod-
ing uncharacterized cyclophilins/cyclophilin-like proteins
is also seen in the P. falciparum genome (Figure 1).
Results and conclusions
All but three of the cyclophilin/cyclophilin-like genes (or
in the case of the larger proteins, their CYP domains)
were cloned identically into a pET vector encoding a
C-terminal His6-tag and eight of them were successfully
expressed in Escherichia coli and purified using nickel-
chelate affinity chromatography. All of the recombinant
proteins showed chaperone activity on model substrates,
while only PfCYP19A and PfCYP19B demonstrated pep-
tidyl-prolyl isomerase (foldase) activity and were bound
by CsA. Our data suggest the existence of a cyclophilin-
type chaperone family whose partner proteins are not
yet known but might include proteins exported to the
host erythrocyte.
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reproduction in any medium, provided the original work is properly cited.Figure 1 Domain architectures of P. falciparum cyclophilin and cyclophilin-like proteins annotated in PlasmoDB. Differently-coloured boxes
indicate recognizable domains; red boxes indicate cyclophilin/cyclophilin-like domains with numbers indicating % identities to human
cyclophilin A(hCYP18). RRM, RNA recognition motif; SP, signal peptide; putMito, putative mitochondrial signal; SYF2, splicing factor 2; WD40,
WD40 domain.
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